These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Severe acute measles pneumonitis: virus isolation in bronchoalveolar lavage fluid. Suter C; Buergi U; Eigenmann K; Franzen D BMJ Case Rep; 2015 Oct; 2015():. PubMed ID: 26508116 [TBL] [Abstract][Full Text] [Related]
44. Giant cell pneumonia: light microscopy, immunohistochemical, and ultrastructural study of an autopsy case. Rahman SM; Eto H; Morshed SA; Itakura H Ultrastruct Pathol; 1996; 20(6):585-91. PubMed ID: 8940766 [TBL] [Abstract][Full Text] [Related]
45. Lymphocyte and lymphocyte subset numbers in blood and bronchoalveolar lavage and pleural fluid in various forms of human pulmonary tuberculosis. Grange JM; Stanford JL; Beck JS Thorax; 1992 Dec; 47(12):1085-6. PubMed ID: 1494779 [No Abstract] [Full Text] [Related]
46. Measles giant cell pneumonia in a child with human immunodeficiency virus infection. Nadel S; McGann K; Hodinka RL; Rutstein R; Chatten J Pediatr Infect Dis J; 1991 Jul; 10(7):542-4. PubMed ID: 1876472 [No Abstract] [Full Text] [Related]
47. Measles and giant-cell pneumonia. ARCHER NE; BIGGS R Med Off; 1947 Nov; 78(22):231-4. PubMed ID: 20273463 [No Abstract] [Full Text] [Related]
48. [Attempted prevention of measles by means of intra-ocular instillation of convalescent sera. Preliminary communication]. JAROSZYNSKA-WEINBERGER B Pediatr Pol; 1960 Mar; 35():345-52. PubMed ID: 14406839 [No Abstract] [Full Text] [Related]
49. [About the effect of measles convalescent urine]. SEFRIN A Arch Kinderheilkd; 1948; 135(1):8-15. PubMed ID: 18894838 [No Abstract] [Full Text] [Related]
50. [Lungs in measles]. DE MATTIA R; MAESTRI O; DI NOLA F; RAPELLINI M; ANGELA GC Minerva Med; 1952 Nov; 43(94):1089-98. PubMed ID: 13025043 [No Abstract] [Full Text] [Related]
51. [Radioclinical considerations on the lungs in measles]. TOSCANO F; PISANI G Pediatrie; 1953; 8(4):563-5. PubMed ID: 13099935 [No Abstract] [Full Text] [Related]
52. Use of Convalescent Measles Serum to Control Measles in a Preparatory School. Gallagher JR Am J Public Health Nations Health; 1935 May; 25(5):595-8. PubMed ID: 18014217 [No Abstract] [Full Text] [Related]
53. [The lung in measles]. SEDALLIAN P; MARAL P Pediatrie; 1950; 5(1):112-6. PubMed ID: 15410474 [No Abstract] [Full Text] [Related]
54. PUBLIC HEALTH ADMINISTRATION: MEASLES CONVALESCENT SERUM. Yaughan HF; Bauer WW Am J Public Health Nations Health; 1931 Mar; 21(3):285-6. PubMed ID: 18013221 [No Abstract] [Full Text] [Related]
55. CONVALESCENT SERUM IN THE PREVENTION OF MEASLES. Warwick W Can Med Assoc J; 1929 Dec; 21(6):694-6. PubMed ID: 20317611 [No Abstract] [Full Text] [Related]
56. The Treatment of Measles with Convalescent Serum. Can Med Assoc J; 1928 Jun; 18(6):734-5. PubMed ID: 20316891 [No Abstract] [Full Text] [Related]
58. PREVENTION OF MEASLES BY CONVALESCENT SERUM. Hunter TM Br Med J; 1933 Feb; 1(3762):217-9. PubMed ID: 20777352 [No Abstract] [Full Text] [Related]
59. T Lymphocytes as Measurable Targets of Protection and Vaccination Against Viral Disorders. Monette A; Mouland AJ Int Rev Cell Mol Biol; 2019; 342():175-263. PubMed ID: 30635091 [TBL] [Abstract][Full Text] [Related]
60. Viral infections in patients with an acute exacerbation of idiopathic interstitial pneumonia. Ushiki A; Yamazaki Y; Hama M; Yasuo M; Hanaoka M; Kubo K Respir Investig; 2014 Jan; 52(1):65-70. PubMed ID: 24388373 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]